Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aminollah Pourshohod
Institution:
Ahvaz Jundishapur University of Medical Sciences
Observed institutions:
Ahvaz Jundishapur University of Medical Sciences,
Yasuj University of Medical Sciences,
Dezful University of Medical Sciences
ORCID:
0000-0002-9162-4497
Observed ORCID:
0000-0002-9162-4497
OpenAlex ID:
A5025828016
Specific delivery of idarubicin to HER2-positive breast cancerous cell line by trastuzumab-conjugated liposomes
2018
·
Mansour Amin
, Aminollah Pourshohod
, et al.
·
Journal of Drug Delivery Science and Technology
·
33
Effects of Nasturtium officinale Extract on Antioxidant and Biochemical Parameters in Hemodialysis Patients: A Randomized Double-Blind Clinical Trial
2021
·
Moslem Sedaghattalab
, Marzieh Razazan
, et al.
·
Evidence-based Complementary and Alternative Medicine
·
23
PDF
Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate
2017
·
Marzieh Ghanemi
, Aminollah Pourshohod
, et al.
·
Current Cancer Drug Targets
·
21
The Effect of the Hydroalcoholic Extract of Watercress on the Levels of Protein Carbonyl, Inflammatory Markers, and Vitamin E in Chronic Hemodialysis Patients
2021
·
Moslem Sedaghattalab
, Marzieh Razazan
, et al.
·
Biochemistry Research International
·
10
PDF
Enhancement of X-ray radiotherapy by specific delivery of ZHER2 affibody-conjugated gold nanoparticles to HER2-positive malignant cells
2019
·
Aminollah Pourshohod
, Mostafa Jamalan
, et al.
·
Journal of Drug Delivery Science and Technology
·
9
3D structure prediction, dynamic investigation and rational construction of an epitope-masked thermostable bovine hyaluronidase
2021
·
Mansour Amin
, Ebrahim Barzegari
, et al.
·
International Journal of Biological Macromolecules
·
8
Improvement of specific aiming of X-ray radiotherapy on HER2-overexpressing cancerous cell lines by targeted delivery of silver nanoparticle
2022
·
Aminollah Pourshohod
, Majid Zeinali
, et al.
·
Journal of Drug Delivery Science and Technology
·
7
Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by ZHER2-Idarubicin Conjugate: An in vitro Study
2021
·
Lila Siavoshinia
, Mostafa Jamalan
, et al.
·
Iranian journal of pathology
·
3
PDF
Investigating new inhibitors with potential advantages for combating HER2-overexpressing head and neck squamous cancer cells; a practical and virtual screening study
2024
·
Majid Zeinali
, Aminollah Pourshohod
, et al.
·
Research Square
·
2
PDF
Cytotoxicity of Sodium Arsenite-loaded Anti-HER2 Immunoliposomes Against HER2-expressing Human Breast Cancer Cell Lines
2018
·
Moslem Afrakhteh
, Alireza Kheirollah
, et al.
·
Letters in Drug Design & Discovery
·
2
Potential Advantages of Idarubicin-Loaded Trastuzumab-Coated Liposomes for Combating Head and Neck Squamous Cancer Cells.
2024
·
Marziyeh Ghanemi
, Aminollah Pourshohod
, et al.
·
PubMed
·
1
PDF
Simulation and practical investigation of carbonic anhydrase stability in an industrial solvent system of methyl diethanolamine for carbon dioxide capture
2024
·
Ebrahim Barzegari
, Shima Ghaedizadeh
, et al.
·
Journal of Biomolecular Structure and Dynamics
Investigating the Combination therapy effect of Trastuzumab and Idarubicin on growth inhibition of HER2-positive breast cancer cells line (SK-BR-3)
2017
·
Moslem Afrakhteh
, Majid Zeinali
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
113: Specific Targeting of Her2-positive Breast Cancer Cell Line (sk-br3) Using Idarubicin-loaded Anti-her2 Immunoliposome
2017
·
Aminollah Pourshohod
, Majid Zeinali
, et al.
·
BMJ Open
PDF
Show more works
View as search
Works count:
14
Citation count:
119
H-index:
7
I10-index:
4
Year
Topic
Type